SEOUL, May 23 (Yonhap) — South Korean vaccine maker SK Bioscience Co. announced Monday that it has won a $31.3 million order from the Pan American Health Organization (PAHO). , to provide varicella vaccines to Latin America.
—
SK Bioscience said that, through PAHO, it recently delivered to Latin American countries its first batch of shipments of SKY Varicella, the company’s chickenpox vaccine, introduced in 2018.
—
SK Bioscience noted that it won the request from PAHO in February.
—
PAHO is an international public health agency that works to improve health standards for the people of the Americas. It belongs to the United Nations system, serving as a regional office for America of the World Health Organization (WHO).
—
In 2019, SKY Varicella, from SK Bioscience, received WHO pre-approval, a requirement to become a supplier to PAHO and other international organizations.
—
